A detailed history of State Of Wisconsin Investment Board transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 343,818 shares of CERE stock, worth $14.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
343,818
Previous 58,297 489.77%
Holding current value
$14.1 Million
Previous $2.47 Million 488.14%
% of portfolio
0.04%
Previous 0.01%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$40.88 - $43.27 $11.7 Million - $12.4 Million
285,521 Added 489.77%
343,818 $14.5 Million
Q4 2023

Feb 12, 2024

BUY
$20.27 - $42.44 $116,086 - $243,053
5,727 Added 10.89%
58,297 $2.47 Million
Q3 2023

Nov 14, 2023

SELL
$20.26 - $31.91 $44,106 - $69,468
-2,177 Reduced 3.98%
52,570 $1.15 Million
Q2 2023

Aug 14, 2023

SELL
$23.9 - $35.38 $69,907 - $103,486
-2,925 Reduced 5.07%
54,747 $1.74 Million
Q1 2023

May 15, 2023

SELL
$22.82 - $35.32 $109,421 - $169,359
-4,795 Reduced 7.68%
57,672 $1.41 Million
Q4 2022

Feb 14, 2023

BUY
$25.35 - $31.96 $73,920 - $93,195
2,916 Added 4.9%
62,467 $1.97 Million
Q3 2022

Nov 14, 2022

BUY
$25.5 - $41.42 $203,821 - $331,070
7,993 Added 15.5%
59,551 $1.68 Million
Q2 2022

Aug 15, 2022

SELL
$20.62 - $37.15 $44,168 - $79,575
-2,142 Reduced 3.99%
51,558 $1.36 Million
Q4 2021

Feb 11, 2022

BUY
$29.21 - $44.64 $236,601 - $361,584
8,100 Added 17.76%
53,700 $1.74 Million
Q2 2021

Aug 12, 2021

BUY
$12.56 - $29.69 $572,736 - $1.35 Million
45,600 New
45,600 $1.17 Million

Others Institutions Holding CERE

About Cerevel Therapeutics Holdings, Inc.


  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Market Cap $6.37B
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.